SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

18 Jul 2016 07:00

RNS Number : 3911E
City of London Investment Group PLC
18 July 2016
 

 

City of London Investment Group PLC

18 July 2016

 

This announcement contains inside information



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

 

TRADING UPDATE

for the year to 30 June 2016

 

City of London (LSE: CLIG), a leading emerging markets asset management group, provides a trading update for its financial year ended 30 June 2016. The numbers that follow are all unaudited.

 

Funds under management were US$4.0 billion (£3.0 billion) at 30 June 2016 (2015: US$4.2 billion or £2.7 billion), representing a 5% decrease in US$ terms and an 11% increase in GBP terms as a result of the exchange rate moving from 1.57 to 1.33 over the period. Over the same period, the MSCI Emerging Markets TR Net Index fell by 12% in US$ terms, resulting in a relative change in funds under management of +7% versus the benchmark, a product of both positive investment performance and new and existing client inflows.

 

Investment performance in the emerging markets closed-end fund (CEF) strategy continues to be strong, with results in the first or second quartile versus manager peers for the year ending 30 June 2016. The current size-weighted average discount (SWAD) across client portfolios is c. 14%-15%, indicating that there is still present significant relative value in the strategy. The investment approach adds value beyond this by exploiting volatility of the underlying discounts in the CEF universe, from which portfolios are constructed with their specific SWAD characteristics plus active country allocation.

 

The Group's overheads for the year to 30 June 2016 are expected to be £10.7 million (2015: £9.4 million) and the current monthly run-rate is c£0.9m.

 

For the year to 30 June 2016, City of London expects that pre-tax profits will be approximately £8.0 million (2015: £8.9 million), and that profits after an anticipated tax charge of £2.0 million (25% of pre-tax profits) will be approximately £5.9 million (2015: profits of £6.6 million after a tax charge of £2.3 million, representing 26% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 23.6p and 23.5p respectively (2015: 26.4p and 26.0p).

 

As a result of the fall in Emerging Markets during the financial year, earnings cover will be reduced this year but given the Group's strong cash position and optimism with regard to the future, the Board is recommending a maintained final dividend of 16p per share (2015: 16p). This would bring the total for the year to 24p (2015: 24p), a dividend cover of 0.98 times earnings per share (2015: 1.1 times).

 

The Board confirms the final dividend timetable for the year to 30 June 2016:

 

· ex-dividend date: 13 October 2016

· dividend record date: 14 October 2016

· payable: 31 October 2016

 

 

City of London expects to announce final results alongside publication of its Accounts for the year to 30 June 2016 on 12 September 2016. The Group's Annual General Meeting will be held on 17 October 2016.

 

Business Update

 

· Virtually all CLIM income is USD based - our fees are sourced from US Institutions

· Zero FUM effect from BREXIT - zero redemptions FYTD

· Over 90% of CLIM income on a see through basis is effectively derived from the Emerging Markets

· Approximately 40% of Group costs are in GBP

· Only 2.5% of CLIM assets are UCIT'S - very little fall out from BREXIT

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/3911E_1-2016-7-17.pdf

 

Assumptions:

- Starting point Current FuM (end June 2016)

- Net increase in FuM in 2016/2017 (straight-lined to June 2017):

· emerging market strategies $250m

· diversification strategies $250m

- Operating margin adjusted monthly for change in product mix and commission run-off

- Market growth: 0%

- Increase in overhead: 5%

- Corporation tax based on an estimated average rate of 26%

- Exchange rate assumed to be £1/$1.35 for entire period

- Number of CLIG Shares in issue (26.9m) less those held by the ESOP Trust (1.9m) as at 30 June 2016

 

This can also be found on our website at: http://www.citlon.co.uk/shareholders/announcements.php

 

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin R Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

 

This release includes forward-looking statements, which may differ from actual results. Any forward-looking statements are based on certain factors and assumptions, which may prove incorrect, and are subject to risks, uncertainties and assumptions relating to future events, the Group's operations, results of operations, growth strategy and liquidity.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFSFAWFMSEIW
Date   Source Headline
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE
23rd May 20244:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.